Status:
UNKNOWN
The Role of NK Cells to Detect Blood Infection in ALL.
Lead Sponsor:
Assiut University
Conditions:
Acute Lymphoblastic Leukemia
Bloodstream Infection
Eligibility:
All Genders
Up to 17 years
Brief Summary
1. Assess possibility of prediction of blood stream infections in ALL patients by profiling of NK cells using flow cytometry. 2. Assess the role of NK cells in development of drug resistance post chem...
Detailed Description
Acute lymphoblastic leukemia (ALL) is the most common malignancy affecting children accounting for approximately 30% of childhood cancers (Zeng XL et al, 2023 ALL is characterized by chromosomal abnor...
Eligibility Criteria
Inclusion
- Patients aged less than 17 years diagnosed as Acute Lymphoblastic Leukemia and on chemotherapy, who are positive for blood stream infection.
Exclusion
- Patients over 17 years of age.
- Presence of other hematological malignancies or history of other malignancies.
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06160115
Start Date
February 1 2024
End Date
April 1 2025
Last Update
December 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.